DMT — the most potent psychedelic known to man — treats people with severe depression after a single dose, a cutting-edge clinical trial suggests. Up to six in ten who received a single dose of DMT ...
Canadian biopharma company Algernon Pharmaceuticals Inc. AGNPF’s subsidiary Algernon NeuroScience (AGN Neuro) completed dosing the second cohort of its Phase 1 study on the company’s proprietary IV ...
VANCOUVER, British Columbia, June 05, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage ...
VANCOUVER, British Columbia, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical ...
Algernon Pharmaceuticals CEO Christopher Moreau joined Steve Darling from Proactive to provide an update on subsidiary Algernon NeuroScience successfully completing the highest planned single dose of ...
From the dark annals of Erowid forums to Joe Rogan’s podcast studio, there’s perhaps no psychoactive drug more enigmatic — and misunderstood — than N,N-Dimethyltryptamine, better known as DMT. The ...
A new study from Imperial College London has found significant overlap between the experiences reported by subjects who have had near-death experiences, and volunteers administered with a powerful ...
People who experiment with microdosing claim that it can help a person to think more creatively, feel less anxious, and sharpen focus. But despite plenty of anecdotal evidence and Silicon Valley’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback